The role of CHFR as a predictive marker of response to taxane-based preoperative chemotherapy in triple-negative breast cancer.
Elisavet Paplomata
No relevant relationships to disclose
Gabriel Sica
No relevant relationships to disclose
Shahrzad Ehdaivand
No relevant relationships to disclose
Dana Nickleach
No relevant relationships to disclose
Yuan Liu
No relevant relationships to disclose
Amelia Bruce Zelnak
No relevant relationships to disclose
Ruth O'Regan
No relevant relationships to disclose
Johann Christoph Brandes
No relevant relationships to disclose